Resyca BV
PrivateLast Round
Corporate Funding
Nov 17, 2020
Est. Valuation
$35.29M
Total Funding Raised
$18M
Company Overview
Resyca BV is a healthcare technology company that specializes in the development and manufacturing of soft mist inhalation and nasal spray devices for pharmaceutical and biotech applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resyca BV Comparables
Compare Resyca BV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medspray B.V. | 85% | |
| Merxin Ltd | 80% | |
| Suzhou Singmed Medical Device Science and Technology Ltd. | 79% | |
Resyca BV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Nov 17, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2026
Grew 33% QoQ from 9 to 12 employees.
- Jan 25, 2025
Monthly visitors grew 108% MoM, reaching 1.8K.
Resyca BV Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Resyca BV's valuation, stock price, and market status.